Overview Of Abdominal Cancer

Abdominal cancer is a type of cancer that occurs when there is an uncontrolled growth of abnormal cells anywhere in the abdomen, the area between the lower chest and the groin. The abdomen consists of many organs, including the stomach, intestines, liver, gallbladder, pancreas, esophagus, and numerous blood vessels. Abdominal cancer is a general term for a variety of cancers.

Common forms of abdominal cancers include:

• Colorectal cancer
• Liver cancer
• Pancreatic cancer
• Kidney cancer (renal cell cancer)
• Stomach cancer (gastric cancer)

Rare forms of abdominal cancer include:

• Adrenocortical cancer (cancer of the adrenal glands, a pair of organs that produce hormones)
• Primary peritoneal cancer (cancer of the lining of the inside of the abdomen that covers many abdominal organs)
• Peritoneal mesothelioma (cancer of the lining of the inside of the abdomen that is caused by exposure to asbestos)

Symptoms Of Abdominal Cancer

Symptoms of abdominal cancer vary depending on the specific type of cancer, stage of advancement, and other factors. Many people experience no symptoms in the early stages of some forms of abdominal cancer, such as colorectal cancer, stomach cancer, pancreatic cancer, and liver cancer. Symptoms of abdominal cancer can also be vague and similar to symptoms of other diseases, disorders and conditions.

Symptoms of abdominal cancer can be similar to symptoms of other conditions. These symptoms include:

• Abdominal pain
• Fatigue
• Fever
• Itchy skin
• Stomach cancer (gastric cancer)
• Loss of appetite
• Night sweats
• Weight loss
• Abdominal mass or swelling
• Anemia
• Hematuria (bloody urine)
• Jaundice (a yellowing of the skin)
• Pallor (very pale skin)
• Shortness of breath

Causes Of Abdominal Cancer

Abdominal cancer occurs when old or damaged cells divide and multiply uncontrollably. The underlying cause of this varies depending on the specific form of cancer. For example:

• Colorectal cancer commonly develops from adenomatous intestinal polyps in the colon that are not removed while still benign.
• Liver cancer is often caused by certain types of liver disease, often chronic hepatitis B or C infection or alcoholism. Liver cancer can also be caused by another cancer in the body that spreads to the liver.
• Stomach cancer is linked to significant risk factors but the exact cause is not known.
• Pancreatic cancer is linked to significant risk factors but the exact cause is not known.
• Renal cancer is not linked to a specific risk factor in most cases.
• Peritoneal mesothelioma, or cancer of the lining of the inside of the abdomen, is caused by exposure to asbestos.

In addition, metastasis from other areas, such as the ovaries, is a key concern.

Abdominal Cancer And Januvia (Sitagliptin)

Brand-name Januvia (Sitagliptin) products are commonly used in the United States and worldwide to treat Diabetes.

One of the types of cancer linked to overexposure to NDMA is Abdominal Cancer.

Many people who have taken Januvia (Sitagliptin) regularly, or have lost a loved one to cancer after using Januvia (Sitagliptin) products, are now suing Januvia (Sitagliptin) drugmakers for failing to disclose the potential link between use of their products and various cancers.

How To Know If Januvia (Sitagliptin) Caused Your Abdominal Cancer

Januvia (Sitagliptin) is a brand name for the generic drug, Sitagliptin. Not all Januvia (Sitagliptin) products are necessarily believed to be contaminated with dangerous amounts of NDMA, according to the U.S. Food and Drug Administration.

If you are concerned about your risk for developing Abdominal Cancer after taking Januvia (Sitagliptin), or wish to know if Januvia (Sitagliptin) caused your Abdominal Cancer, your best course of action is to talk to your doctor or cancer treatment team. Your doctor can evaluate your risk, or probable causes of your Abdominal Cancer through careful consideration of your medical history and Januvia (Sitagliptin) use.

At this time, the FDA does not know how many people are likely to have been affected by the toxic amounts of NDMA in Januvia (Sitagliptin) and Januvia (Sitagliptin) products. An investigation into the scope of the issue and the likelihood of developing cancer after taking Januvia (Sitagliptin) is currently ongoing.

What To Do If You Think Januvia (Sitagliptin) Caused Your Abdominal Cancer

If you were diagnosed with Leukemia after taking Januvia (Sitagliptin) regularly for a health problem, you are not alone. Several class action and individual lawsuits have been filed across the U.S. by individuals and loved ones who received a cancer diagnosis after taking Januvia (Sitagliptin) or Januvia (Sitagliptin) products.

The basis for these lawsuits is generally one of negligence. Negligence is a legal theory in personal injury law that traces personal injury or wrongful death to the negligent behavior of an individual or entity—such as a business or pharmaceutical company.

At this time, the FDA does not know how many people are likely to have been affected by the toxic amounts of NDMA in Januvia (Sitagliptin) and Januvia (Sitagliptin) products. An investigation into the scope of the issue and the likelihood of developing cancer after taking Januvia (Sitagliptin) is currently ongoing.

The types of Januvia (Sitagliptin) cancer lawsuits that have been filed include:

• Product liability (defective drug) lawsuits
• Personal injury lawsuits
• Wrongful death lawsuits

Several plaintiffs who have taken legal action against Januvia (Sitagliptin) drugmakers have not been diagnosed with cancer, but are nonetheless seeking compensation for the amount of money spent on Januvia (Sitagliptin) through their regular use of the drugs.

If you’ve been diagnosed with Abdominal Cancer after taking Januvia (Sitagliptin) and experienced significant financial or emotional distress, an attorney will likely recommend filing an individual lawsuit to seek fair compensation for your losses. You may be eligible to file a Januvia (Sitagliptin) lawsuit for Abdominal Cancer.

You can determine your eligibility for filing an individual lawsuit by speaking to an experienced dangerous drug attorney.

Symptoms Of Bladder Cancer

Bladder cancer signs and symptoms may include:

• Blood in urine (hematuria)
• Painful urination
• Pelvic pain

If you have hematuria, your urine may appear bright red or cola colored. Sometimes, urine may not look any different, but blood in urine may be detected during a microscopic exam of the urine. People with bladder cancer might also experience:

• Back pain
• Frequent urination

But, these symptoms often occur because of something other than bladder cancer.

Causes Of Bladder Cancer

Bladder cancer develops when cells in the bladder begin to grow abnormally. Rather than grow and divide in an orderly way, these cells develop mutations that cause them to grow out of control and not die. These abnormal cells form a tumor.

Causes of bladder cancer include:

• Smoking and other tobacco use
• Exposure to chemicals, especially working in a job that requires exposure to chemicals
• Past radiation exposuren
• Chronic irritation of the lining of the bladder
• Parasitic infections, especially in people who are from or have traveled to certain areas outside the United States

It's not always clear what causes bladder cancer, and some people with bladder cancer have no obvious risk factors. Investigations are currently being conducted regarding the link to Januvia (Sitagliptin) Bladder Cancer.

Bladder Cancer And Januvia (Sitagliptin)

Brand-name Januvia (Sitagliptin) products are commonly used in the United States and worldwide to treat Diabetes.

One of the types of cancer linked to overexposure to NDMA is bladder cancer.

Many people who have taken Januvia (Sitagliptin) regularly, or have lost a loved one to cancer after using Januvia (Sitagliptin) products, are now suing Januvia (Sitagliptin) drugmakers for failing to disclose the potential link between use of their products and various cancers.

How To Know If Januvia (Sitagliptin) Caused Your Bladder Cancer

Januvia (Sitagliptin) is a brand name for the generic drug, Januvia (Sitagliptin). Not all Januvia (Sitagliptin) products are necessarily believed to be contaminated with dangerous amounts of NDMA, according to the U.S. Food and Drug Administration.

If you are concerned about your risk for developing bladder cancer after taking Januvia (Sitagliptin), or wish to know if Januvia (Sitagliptin) caused your bladder cancer, your best course of action is to talk to your doctor or cancer treatment team. Your doctor can evaluate your risk, or probable causes of your bladder cancer through careful consideration of your medical history and Januvia (Sitagliptin) use.

At this time, the FDA does not know how many people are likely to have been affected by the toxic amounts of NDMA in Januvia (Sitagliptin) and Januvia (Sitagliptin) products. An investigation into the scope of the issue and the likelihood of developing cancer after taking Januvia (Sitagliptin) is currently ongoing.

What To Do If You Think Januvia (Sitagliptin) Caused Your Bladder Cancer

If you were diagnosed with kidney cancer after taking Januvia (Sitagliptin) regularly for a health problem, you are not alone. Several class action and individual lawsuits have been filed across the U.S. by individuals and loved ones who received a cancer diagnosis after taking Januvia (Sitagliptin) or Januvia (Sitagliptin) products.

The basis for these lawsuits is generally one of negligence. Negligence is a legal theory in personal injury law that traces personal injury or wrongful death to the negligent behavior of an individual or entity—such as a business or pharmaceutical company.

In the context of recent Januvia (Sitagliptin) lawsuits, the negligence of named defendants (Januvia (Sitagliptin) drugmakers) refers to their failure to properly warn the government, healthcare providers, and the public of the amount of NDMA in their drugs, violating U.S. consumer protection laws.

The types of Januvia (Sitagliptin) cancer lawsuits that have been filed include:

• Product liability (defective drug) lawsuits
• Personal injury lawsuits
• wrongful death lawsuits

Several plaintiffs who have taken legal action against Januvia (Sitagliptin) drugmakers have not been diagnosed with cancer, but are nonetheless seeking compensation for the amount of money spent on Januvia (Sitagliptin) through their regular use of the drugs.

If you’ve been diagnosed with bladder cancer after taking Januvia (Sitagliptin) and experienced significant financial or emotional distress, an attorney will likely recommend filing an individual lawsuit to seek fair compensation for your losses. You may be eligible to file a Januvia (Sitagliptin) lawsuit for bladder cancer.

You can determine your eligibility for filing an individual lawsuit by speaking to an experienced dangerous drug attorney.

Breast Cancer

Overview

Breast cancer is cancer that forms in the cells of the breasts. After skin cancer, breast cancer is the most common cancer diagnosed in women in the United States. Breast cancer can occur in both men and women, but it's far more common in women.

Changes or mutations in DNA can cause normal breast cells to become cancer. Certain DNA changes are passed on from parents (inherited) and can greatly increase your risk for breast cancer. Other lifestyle-related risk factors, such as what you eat and how much you exercise, can increase your chance of developing breast cancer, but it’s not yet known exactly how some of these risk factors cause normal cells to become cancer. Hormones seem to play a role in many cases of breast cancer, but just how this happens is not fully understood.

Symptoms

Signs and symptoms of breast cancer may include:

• A breast lump or thickening that feels different from the surrounding tissue
• Change in the size, shape or appearance of a breast
• Changes to the skin over the breast, such as dimpling
• A newly inverted nipple
• Peeling, scaling, crusting or flaking of the pigmented area of skin surrounding the nipple (areola) or breast skin
• Redness or pitting of the skin over your breast, like the skin of an orange

Causes

Doctors know that breast cancer occurs when some breast cells begin to grow abnormally. These cells divide more rapidly than healthy cells do and continue to accumulate, forming a lump or mass. Cells may spread (metastasize) through your breast to your lymph nodes or to other parts of your body.

Breast cancer most often begins with cells in the milk-producing ducts (invasive ductal carcinoma). Breast cancer may also begin in the glandular tissue called lobules (invasive lobular carcinoma) or in other cells or tissue within the breast.

Researchers have identified hormonal, lifestyle and environmental factors that may increase your risk of breast cancer. But it's not clear why some people who have no risk factors develop cancer, yet other people with risk factors never do. It's likely that breast cancer is caused by a complex interaction of your genetic makeup and your environment.

Breast Cancer & Januvia (Sitagliptin)

Brand-name Januvia (Sitagliptin) products are commonly used in the United States and worldwide to treat Diabetes.

One of the types of cancer linked to overexposure to NDMA is stomach (gastric) cancer. Stomach cancer is diagnosed in an estimated 27,600 people in the U.S. each year, mostly in adults aged 65 and older.

Many people who have taken Januvia (Sitagliptin) regularly, or have lost a loved one to cancer after using Januvia (Sitagliptin) products, are now suing Januvia (Sitagliptin) drugmakers for failing to disclose the potential link between use of their products and various cancers.

How To Know If Januvia (Sitagliptin) Caused Your Breast Cancer

Januvia (Sitagliptin) is a brand name for the generic drug, Januvia (Sitagliptin). Not all Januvia (Sitagliptin) products are necessarily believed to be contaminated with dangerous amounts of NDMA, according to the U.S. Food and Drug Administration.

If you are concerned about your risk for developing breast cancer after taking Januvia (Sitagliptin), or wish to know if Januvia (Sitagliptin) caused your stomach cancer, your best course of action is to talk to your doctor or cancer treatment team. Your doctor can evaluate your risk, or probable causes of your stomach cancer through careful consideration of your medical history and Januvia (Sitagliptin) use.

At this time, the FDA does not know how many people are likely to have been affected by the toxic amounts of NDMA in Januvia (Sitagliptin) and Januvia (Sitagliptin) products. An investigation into the scope of the issue and the likelihood of developing cancer after taking Januvia (Sitagliptin) is currently ongoing.

What To Do If You Think Januvia (Sitagliptin) Caused Your Breast Cancer

If you were diagnosed with breast cancer after taking Januvia (Sitagliptin) regularly for a health problem, you are not alone. Several class action and individual lawsuits have been filed across the U.S. by individuals and loved ones who received a cancer diagnosis after taking Januvia (Sitagliptin) or Januvia (Sitagliptin) products.

The basis for these lawsuits is generally one of negligence. Negligence is a legal theory in personal injury law that traces personal injury or wrongful death to the negligent behavior of an individual or entity—such as a business or pharmaceutical company.

In the context of recent Januvia (Sitagliptin) lawsuits, the negligence of named defendants (Januvia (Sitagliptin) drugmakers) refers to their failure to properly warn the government, healthcare providers, and the public of the amount of NDMA in their drugs, violating U.S. consumer protection laws.

The types of Januvia (Sitagliptin) cancer lawsuits that have been filed include:

• Product liability (defective drug) lawsuits
• Personal injury lawsuits
• Wrongful death lawsuits

Several plaintiffs who have taken legal action against Januvia (Sitagliptin) drugmakers have not been diagnosed with cancer, but are nonetheless seeking compensation for the amount of money spent on Januvia (Sitagliptin) through their regular use of the drugs.

If you’ve been diagnosed with breast cancer after taking Januvia (Sitagliptin) and experienced significant financial or emotional distress, an attorney will likely recommend filing an individual lawsuit to seek fair compensation for your losses.

You can determine your eligibility for filing an individual lawsuit by speaking to an experienced dangerous drug attorney.

Colon Cancer

Overview Of Colorectal Cancer

Colon cancer is a type of cancer that begins in the large intestine (colon). The colon is the final part of the digestive tract.

Colon cancer typically affects older adults, though it can happen at any age. It usually begins as small, noncancerous (benign) clumps of cells called polyps that form on the inside of the colon. Over time some of these polyps can become colon cancers.

Polyps may be small and produce few, if any, symptoms. For this reason, doctors recommend regular screening tests to help prevent colon cancer by identifying and removing polyps before they turn into cancer.

If colon cancer develops, many treatments are available to help control it, including surgery, radiation therapy and drug treatments, such as chemotherapy, targeted therapy and immunotherapy.

Colon cancer is sometimes called colorectal cancer, which is a term that combines colon cancer and rectal cancer, which begins in the rectum.

Symptoms Of Colon Cancer

Signs and symptoms of colon cancer include:

• A persistent change in your bowel habits, including diarrhea or constipation or a change in the consistency of your stool
• Rectal bleeding or blood in your stool
• Persistent abdominal discomfort, such as cramps, gas or pain
• A feeling that your bowel doesn't empty completely
• Weakness or fatigue
• Unexplained weight loss

Many people with colon cancer experience no symptoms in the early stages of the disease. When symptoms appear, they'll likely vary, depending on the cancer's size and location in your large intestine.

Causes Of Colon Cancer

Doctors aren't certain what causes most colon cancers.

In general, colon cancer begins when healthy cells in the colon develop changes (mutations) in their DNA. A cell's DNA contains a set of instructions that tell a cell what to do.

Healthy cells grow and divide in an orderly way to keep your body functioning normally. But when a cell's DNA is damaged and becomes cancerous, cells continue to divide — even when new cells aren't needed. As the cells accumulate, they form a tumor.

With time, the cancer cells can grow to invade and destroy normal tissue nearby. And cancerous cells can travel to other parts of the body to form deposits there (metastasis).

Colorectal Cancer And Januvia (Sitagliptin)

Brand-name Januvia (Sitagliptin) products are commonly used in the United States and worldwide to treat Diabetes.

One of the types of cancer linked to overexposure to NDMA is colorectal cancer.

Many people who have taken Januvia (Sitagliptin) regularly, or have lost a loved one to cancer after using Januvia (Sitagliptin) products, are now suing Januvia (Sitagliptin) drugmakers for failing to disclose the potential link between use of their products and various cancers.

How To Know If Januvia (Sitagliptin) Caused Your Colorectal Cancer

Januvia (Sitagliptin) is a brand name for the generic drug, Januvia (Sitagliptin). Not all Januvia (Sitagliptin) products are necessarily believed to be contaminated with dangerous amounts of NDMA, according to the U.S. Food and Drug Administration.

If you are concerned about your risk for developing colon cancer after taking Januvia (Sitagliptin), or wish to know if Januvia (Sitagliptin) caused your colorectal cancer, your best course of action is to talk to your doctor or cancer treatment team. Your doctor can evaluate your risk, or probable causes of your colon cancer through careful consideration of your medical history and Januvia (Sitagliptin) use.

At this time, the FDA does not know how many people are likely to have been affected by the toxic amounts of NDMA in Januvia (Sitagliptin) and Januvia (Sitagliptin) products. An investigation into the scope of the issue and the likelihood of developing cancer after taking Januvia (Sitagliptin) is currently ongoing.

What To Do If You Think Januvia (Sitagliptin) Caused Your Colon Cancer Lawsuit

If you were diagnosed with colorectal cancer after taking Januvia (Sitagliptin) regularly for a health problem, you are not alone. Several class action and individual lawsuits have been filed across the U.S. by individuals and loved ones who received a cancer diagnosis after taking Januvia (Sitagliptin) or Januvia (Sitagliptin) products.

The basis for these lawsuits is generally one of negligence. Negligence is a legal theory in personal injury law that traces personal injury or wrongful death to the negligent behavior of an individual or entity—such as a business or pharmaceutical company.

In the context of recent Januvia (Sitagliptin) lawsuits, the negligence of named defendants (Januvia (Sitagliptin) drugmakers) refers to their failure to properly warn the government, healthcare providers, and the public of the amount of NDMA in their drugs, violating U.S. consumer protection laws.

The types of Januvia (Sitagliptin) cancer lawsuits that have been filed include:

• Product liability (defective drug) lawsuits
• Personal injury lawsuits
• Wrongful death lawsuits

Several plaintiffs who have taken legal action against Januvia (Sitagliptin) drugmakers have not been diagnosed with cancer, but are nonetheless seeking compensation for the amount of money spent on Januvia (Sitagliptin) through their regular use of the drugs.

If you’ve been diagnosed with colorectal or colon cancer after taking Januvia (Sitagliptin) and experienced significant financial or emotional distress, an attorney will likely recommend filing an individual lawsuit to seek fair compensation for your losses.

You can determine your eligibility for filing an individual lawsuit by speaking to an experienced dangerous drug attorney.

Esophageal Cancer

Overview Of Esophageal Cancer

Esophageal cancer is cancer that occurs in the esophagus — a long, hollow tube that runs from your throat to your stomach. Your esophagus helps move the food you swallow from the back of your throat to your stomach to be digested.

Esophageal cancer usually begins in the cells that line the inside of the esophagus. Esophageal cancer can occur anywhere along the esophagus. More men than women get esophageal cancer.

Esophageal cancer is the sixth most common cause of cancer deaths worldwide. Incidence rates vary within different geographic locations. In some regions, higher rates of esophageal cancer may be attributed to tobacco and alcohol use or particular nutritional habits and obesity.

Symptoms Of Esophageal Cancer

Signs and symptoms of esophageal cancer include:

• Difficulty swallowing (dysphagia)
• Weight loss without trying
• Chest pain, pressure or burning
• Worsening indigestion or heartburn
• Coughing or hoarseness

Early esophageal cancer typically causes no signs or symptoms.

Causes Of Esophageal Cancer

It's not exactly clear what causes esophageal cancer.

Esophageal cancer occurs when cells in the esophagus develop changes (mutations) in their DNA. The changes make cells grow and divide out of control. The accumulating abnormal cells form a tumor in the esophagus that can grow to invade nearby structures and spread to other parts of the body.

Types Of Esophageal Cancer

Esophageal cancer is classified according to the type of cells that are involved. The type of esophageal cancer you have helps determine your treatment options. Types of esophageal cancer include:

Adenocarcinoma: Adenocarcinoma begins in the cells of mucus-secreting glands in the esophagus. Adenocarcinoma occurs most often in the lower portion of the esophagus. Adenocarcinoma is the most common form of esophageal cancer in the United States, and it affects primarily white men.

Squamous cell carcinoma: The squamous cells are flat, thin cells that line the surface of the esophagus. Squamous cell carcinoma occurs most often in the upper and middle portions of the esophagus. Squamous cell carcinoma is the most prevalent esophageal cancer worldwide.

Other rare types: Some rare forms of esophageal cancer include small cell carcinoma, sarcoma, lymphoma, melanoma and choriocarcinoma.

Esophageal Cancer And Januvia (Sitagliptin)

Brand-name Januvia (Sitagliptin) products are commonly used in the United States and worldwide to treat Diabetes.

One of the types of cancer linked to overexposure to NDMA is colorectal cancer.

Many people who have taken Januvia (Sitagliptin) regularly, or have lost a loved one to cancer after using Januvia (Sitagliptin) products, are now suing Januvia (Sitagliptin) drugmakers for failing to disclose the potential link between use of their products and various cancers.

How To Know If Januvia (Sitagliptin) Caused Your Esophageal Cancer

Januvia (Sitagliptin) is a brand name for the generic drug, Januvia (Sitagliptin). Not all Januvia (Sitagliptin) products are necessarily believed to be contaminated with dangerous amounts of NDMA, according to the U.S. Food and Drug Administration.

If you are concerned about your risk for developing esophageal cancer after taking Januvia (Sitagliptin), or wish to know if Januvia (Sitagliptin) caused your esophageal cancer, your best course of action is to talk to your doctor or cancer treatment team. Your doctor can evaluate your risk, or probable causes of your intestinal cancer through careful consideration of your medical history and Januvia (Sitagliptin) use.

At this time, the FDA does not know how many people are likely to have been affected by the toxic amounts of NDMA in Januvia (Sitagliptin) and Januvia (Sitagliptin) products. An investigation into the scope of the issue and the likelihood of developing cancer after taking Januvia (Sitagliptin) is currently ongoing.

What To Do If You Think Januvia (Sitagliptin) Caused Your Esophageal Cancer

If you were diagnosed with intestinal cancer after taking Januvia (Sitagliptin) regularly for a health problem, you are not alone. Several class action and individual lawsuits have been filed across the U.S. by individuals and loved ones who received a cancer diagnosis after taking Januvia (Sitagliptin) or Januvia (Sitagliptin) products.

The basis for these lawsuits is generally one of negligence. Negligence is a legal theory in personal injury law that traces personal injury or wrongful death to the negligent behavior of an individual or entity—such as a business or pharmaceutical company.

In the context of recent Januvia (Sitagliptin) lawsuits, the negligence of named defendants (Januvia (Sitagliptin) drugmakers) refers to their failure to properly warn the government, healthcare providers, and the public of the amount of NDMA in their drugs, violating U.S. consumer protection laws.

The types of Januvia (Sitagliptin) cancer lawsuits that have been filed include:

• Product liability (defective drug) lawsuits
• Personal injury lawsuits
• Wrongful death lawsuits

Several plaintiffs who have taken legal action against Januvia (Sitagliptin) drugmakers have not been diagnosed with cancer, but are nonetheless seeking compensation for the amount of money spent on Januvia (Sitagliptin) through their regular use of the drugs.

If you’ve been diagnosed with esophageal cancer after taking Januvia (Sitagliptin) and experienced significant financial or emotional distress, an attorney will likely recommend filing an individual lawsuit to seek fair compensation for your losses.

You can determine your eligibility for filing an individual lawsuit by speaking to an experienced dangerous drug attorney.

Intestinal Cancer

Overview

As with most cancers, intestinal cancer develops when defective or mutated cells grow out of control and form a tumor. Intestinal cancer, also called small intestine cancer or small bowel cancer, usually starts in the lining of the small intestine and may spread to other parts of the body. Most cases of intestinal cancer develop in the duodenum, or upper part of the organ.

The main types of small intestine cancer include:

• Adenocarcinomas, the most common type of small intestine cancer, usually develop in the cells that line the walls of the small intestine. Often, this type of cancer will develop out of small benign (noncancerous) growths called polyps.
• Sarcoma is a type of intestinal cancer that develops in the connective tissue of the small intestine.
• Gastrointestinal stromal tumors are variants of soft tissue sarcoma.
• Carcinoid tumors form in the lining of the intestines and are often are slow-growing.
• Lymphomas are an immune system disease that may originate in the intestines.

Symptoms

Some common symptoms of cancer that develops in the small intestines include:

• Abdominal pain
• Unexplained weight loss
• Weakness or fatigue (sometimes a result of anemia)
• Bloody or tarry stools (from bleeding tumors)
• A noticeable lump in the abdomen

Causes

Inherited condition: Although most small intestine cancers occur without a known hereditary link, there are some inherited conditions that may lead to a higher risk. The inherited conditions associated specifically with small intestine adenocarcinoma are:

• Familial adenomatous polyposis (FAP)
• Hereditary nonpolyposis colorectal cancer (HNPCC), also called Lynch syndrome
• Peutz-Jeghers syndrome (PJS)
• Cystic fibrosis (CF)
• People with either multiple endocrine neoplasia, type I (MEN1) or defects in the gene NF1 (type 1 neurofibromatosis) may develop benign tumors in the small intestine that are at risk of becoming malignant carcinoid tumors.
• Gardner syndrome: Caused by a genetic defect. People with this syndrome often develop many polyps throughout the GI tract, particularly in the colon. Although there is a greater risk for developing colon cancer, this disease is considered a risk factor for sarcomas of the small intestine.
• Von Recklinghausen's disease: Neurofibromatosis, an inherited gene mutation, may lead to GISTs. However, there usually is no known cause for GISTs of the small intestine and hereditary links are rare.
• Tobacco and alcohol use: Lots of evidence links cigarette smoking and alcohol abuse to many types cancer. Some research suggests that smoking and drinking may also be associated with small intestine cancer.
• Diet: Eating a high-fat diet may be a small intestine risk factor.
• Chemical exposure: Certain chemicals, like vinyl chloride, dioxins and high doses of herbicides containing phenoxyacetic acid, are considered intestinal cancer risk factors for certain types of sarcomas, possibly including sarcomas in the small intestine. NDMA in Januvia (Sitagliptin) has also been linked to cancer.

Intestinal Cancer & Januvia (Sitagliptin)

Brand-name Januvia (Sitagliptin) products are commonly used in the United States and worldwide to treat Diabetes.

Recent concerns have emerged about the safety of Januvia (Sitagliptin), One of the types of cancer linked to overexposure to NDMA is intestinal cancer.

Many people who have taken Januvia (Sitagliptin) regularly, or have lost a loved one to cancer after using Januvia (Sitagliptin) products, are now suing Januvia (Sitagliptin) drugmakers for failing to disclose the potential link between use of their products and various cancers.

How To Know If Januvia (Sitagliptin) Caused Your Intestinal Cancer

Januvia (Sitagliptin) is a brand name for the generic drug, Januvia (Sitagliptin). Not all Januvia (Sitagliptin) products are necessarily believed to be contaminated with dangerous amounts of NDMA, according to the U.S. Food and Drug Administration.

If you are concerned about your risk for developing intestinal cancer after taking Januvia (Sitagliptin), or wish to know if Januvia (Sitagliptin) caused your intestinal cancer, your best course of action is to talk to your doctor or cancer treatment team. Your doctor can evaluate your risk, or probable causes of your intestinal cancer through careful consideration of your medical history and Januvia (Sitagliptin) use.

At this time, the FDA does not know how many people are likely to have been affected by the toxic amounts of NDMA in Januvia (Sitagliptin) and Januvia (Sitagliptin) products. An investigation into the scope of the issue and the likelihood of developing cancer after taking Januvia (Sitagliptin) is currently ongoing.

What To Do If You Think Januvia (Sitagliptin) Caused Your Intestinal Cancer

If you were diagnosed with intestinal cancer after taking Januvia (Sitagliptin) regularly for a health problem, you are not alone. Several class action and individual lawsuits have been filed across the U.S. by individuals and loved ones who received a cancer diagnosis after taking Januvia (Sitagliptin) or Januvia (Sitagliptin) products.

The basis for these lawsuits is generally one of negligence. Negligence is a legal theory in personal injury law that traces personal injury or wrongful death to the negligent behavior of an individual or entity—such as a business or pharmaceutical company.

In the context of recent Januvia (Sitagliptin) lawsuits, the negligence of named defendants (Januvia (Sitagliptin) drugmakers) refers to their failure to properly warn the government, healthcare providers, and the public of the amount of NDMA in their drugs, violating U.S. consumer protection laws.

The types of Januvia (Sitagliptin) cancer lawsuits that have been filed include:

• Product liability (defective drug) lawsuits
• Personal injury lawsuits
• Wrongful death lawsuits

Several plaintiffs who have taken legal action against Januvia (Sitagliptin) drugmakers have not been diagnosed with cancer, but are nonetheless seeking compensation for the amount of money spent on Januvia (Sitagliptin) through their regular use of the drugs.

If you’ve been diagnosed with intestinal cancer after taking Januvia (Sitagliptin) and experienced significant financial or emotional distress, an attorney will likely recommend filing an individual lawsuit to seek fair compensation for your losses.

You can determine your eligibility for filing an individual lawsuit by speaking to an experienced dangerous drug attorney.

Kidney Cancer

Overview Of Kidney Cancer

Kidney cancer is cancer that begins in the kidneys. Your kidneys are two bean-shaped organs, each about the size of your fist. They're located behind your abdominal organs, with one kidney on each side of your spine.

In adults, renal cell carcinoma is the most common type of kidney cancer. Other less common types of kidney cancer can occur. Young children are more likely to develop a kind of kidney cancer called Wilms' tumor.

The incidence of kidney cancer seems to be increasing. One reason for this may be the fact that imaging techniques such as computerized tomography (CT) scans are being used more often. These tests may lead to the accidental discovery of more kidney cancers. Kidney cancer is often discovered at an early stage, when the cancer is small and confined to the kidney.

Symptoms Of Kidney Cancer

Kidney cancer usually doesn't have signs or symptoms in its early stages. In time, signs and symptoms may develop, including:

• Blood in your urine, which may appear pink, red or cola colored
• Pain in your back or side that doesn't go away
• Loss of appetite
• Unexplained weight loss
• Tiredness
• Fever

Causes Of Kidney Cancer

It's not clear what causes most kidney cancers.

Doctors know that kidney cancer begins when some kidney cells develop changes (mutations) in their DNA. A cell's DNA contains the instructions that tell a cell what to do. The changes tell the cells to grow and divide rapidly. The accumulating abnormal cells form a tumor that can extend beyond the kidney. Some cells can break off and spread (metastasize) to distant parts of the body.

Kidney Cancer And Januvia (Sitagliptin)

Brand-name Januvia (Sitagliptin) products are commonly used in the United States and worldwide to treat Diabetes.

One of the types of cancer linked to overexposure to NDMA is kidney cancer.

Many people who have taken Januvia (Sitagliptin) regularly, or have lost a loved one to cancer after using Januvia (Sitagliptin) products, are now suing Januvia (Sitagliptin) drugmakers for failing to disclose the potential link between use of their products and various cancers.

How To Know If Januvia (Sitagliptin) Caused Your Kidney Cancer

Januvia (Sitagliptin) is a brand name for the generic drug, Januvia (Sitagliptin). Not all Januvia (Sitagliptin) products are necessarily believed to be contaminated with dangerous amounts of NDMA, according to the U.S. Food and Drug Administration.

If you are concerned about your risk for developing kidney cancer after taking Januvia (Sitagliptin), or wish to know if Januvia (Sitagliptin) caused your kidney cancer, your best course of action is to talk to your doctor or cancer treatment team. Your doctor can evaluate your risk, or probable causes of your kidney cancer through careful consideration of your medical history and Januvia (Sitagliptin) use.

At this time, the FDA does not know how many people are likely to have been affected by the toxic amounts of NDMA in Januvia (Sitagliptin) and Januvia (Sitagliptin) products. An investigation into the scope of the issue and the likelihood of developing cancer after taking Januvia (Sitagliptin) is currently ongoing.

What To Do If You Think Januvia (Sitagliptin) Caused Your Kidney Cancer

If you were diagnosed with kidney cancer after taking Januvia (Sitagliptin) regularly for a health problem, you are not alone. Several class action and individual lawsuits have been filed across the U.S. by individuals and loved ones who received a cancer diagnosis after taking Januvia (Sitagliptin) or Januvia (Sitagliptin) products.

The basis for these lawsuits is generally one of negligence. Negligence is a legal theory in personal injury law that traces personal injury or wrongful death to the negligent behavior of an individual or entity—such as a business or pharmaceutical company.

In the context of recent Januvia (Sitagliptin) lawsuits, the negligence of named defendants (Januvia (Sitagliptin) drugmakers) refers to their failure to properly warn the government, healthcare providers, and the public of the amount of NDMA in their drugs, violating U.S. consumer protection laws.

The types of Januvia (Sitagliptin) cancer lawsuits that have been filed include:

• Product liability (defective drug) lawsuits
• Personal injury lawsuits
• Wrongful death lawsuits

Several plaintiffs who have taken legal action against Januvia (Sitagliptin) drugmakers have not been diagnosed with cancer, but are nonetheless seeking compensation for the amount of money spent on Januvia (Sitagliptin) through their regular use of the drugs.

If you’ve been diagnosed with kidney cancer after taking Januvia (Sitagliptin) and experienced significant financial or emotional distress, an attorney will likely recommend filing an individual lawsuit to seek fair compensation for your losses. You may be eligible to file a Januvia (Sitagliptin) lawsuit for kidney cancer.

You can determine your eligibility for filing an individual lawsuit by speaking to an experienced dangerous drug attorney.

Leukemia

Overview Of Leukemia

Leukemia is cancer of the body's blood-forming tissues, including the bone marrow and the lymphatic system.

Many types of leukemia exist. Some forms of leukemia are more common in children. Other forms of leukemia occur mostly in adults.

Leukemia usually involves the white blood cells. Your white blood cells are potent infection fighters — they normally grow and divide in an orderly way, as your body needs them. But in people with leukemia, the bone marrow produces abnormal white blood cells, which don't function properly.

Treatment for leukemia can be complex — depending on the type of leukemia and other factors. But there are strategies and resources that can help to make your treatment successful.

Symptoms Of Leukemia

Leukemia symptoms vary, depending on the type of leukemia. Common leukemia signs and symptoms include:

• Fever or chills
• Persistent fatigue, weakness
• Frequent or severe infections
• Losing weight without trying
• Swollen lymph nodes, enlarged liver or spleen
• Easy bleeding or bruising
• Recurrent nosebleeds
• Tiny red spots in your skin (petechiae)
• Excessive sweating, especially at night
• Bone pain or tenderness

Causes Of Leukemia

Scientists don't understand the exact causes of leukemia. It seems to develop from a combination of genetic and environmental factors.

In general, leukemia is thought to occur when some blood cells acquire mutations in their DNA — the instructions inside each cell that guide its action. There may be other changes in the cells that have yet to be fully understood that could contribute to leukemia.

Certain abnormalities cause the cell to grow and divide more rapidly and to continue living when normal cells would die. Over time, these abnormal cells can crowd out healthy blood cells in the bone marrow, leading to fewer healthy white blood cells, red blood cells and platelets, causing the signs and symptoms of leukemia.

How leukemia is classified

Doctors classify leukemia based on its speed of progression and the type of cells involved.

The first type of classification is by how fast the leukemia progresses:

• Acute leukemia. In acute leukemia, the abnormal blood cells are immature blood cells (blasts). They can't carry out their normal functions, and they multiply rapidly, so the disease worsens quickly. Acute leukemia requires aggressive, timely treatment.
• Chronic leukemia. There are many types of chronic leukemias. Some produce too many cells and some cause too few cells to be produced. Chronic leukemia involves more mature blood cells. These blood cells replicate or accumulate more slowly and can function normally for a period of time. Some forms of chronic leukemia initially produce no early symptoms and can go unnoticed or undiagnosed for years.

The second type of classification is by type of white blood cell affected:

• Lymphocytic leukemia. This type of leukemia affects the lymphoid cells (lymphocytes), which form lymphoid or lymphatic tissue. Lymphatic tissue makes up your immune system.
• Myelogenous (my-uh-LOHJ-uh-nus) leukemia. This type of leukemia affects the myeloid cells. Myeloid cells give rise to red blood cells, white blood cells and platelet-producing cells.

Leukemia And Januvia (Sitagliptin)

Brand-name Januvia (Sitagliptin) products are commonly used in the United States and worldwide to treat Diabetes.

One of the types of cancer linked to overexposure to NDMA is Leukemia.

Many people who have taken Januvia (Sitagliptin) regularly, or have lost a loved one to cancer after using Januvia (Sitagliptin) products, are now suing Januvia (Sitagliptin) drugmakers for failing to disclose the potential link between use of their products and various cancers.

How To Know If Januvia (Sitagliptin) Caused Your Leukemia

Januvia (Sitagliptin) is a brand name for the generic drug, Januvia (Sitagliptin). Not all Januvia (Sitagliptin) products are necessarily believed to be contaminated with dangerous amounts of NDMA, according to the U.S. Food and Drug Administration.

If you are concerned about your risk for developing Leukemia after taking Januvia (Sitagliptin), or wish to know if Januvia (Sitagliptin) caused your Leukemia, your best course of action is to talk to your doctor or cancer treatment team. Your doctor can evaluate your risk, or probable causes of your Leukemia through careful consideration of your medical history and Januvia (Sitagliptin) use.

At this time, the FDA does not know how many people are likely to have been affected by the toxic amounts of NDMA in Januvia (Sitagliptin) and Januvia (Sitagliptin) products. An investigation into the scope of the issue and the likelihood of developing cancer after taking Januvia (Sitagliptin) is currently ongoing.

What To Do If You Think Januvia (Sitagliptin) Caused Your Leukemia

If you were diagnosed with Leukemia after taking Januvia (Sitagliptin) regularly for a health problem, you are not alone. Several class action and individual lawsuits have been filed across the U.S. by individuals and loved ones who received a cancer diagnosis after taking Januvia (Sitagliptin) or Januvia (Sitagliptin) products.

The basis for these lawsuits is generally one of negligence. Negligence is a legal theory in personal injury law that traces personal injury or wrongful death to the negligent behavior of an individual or entity—such as a business or pharmaceutical company.

In the context of recent Januvia (Sitagliptin) lawsuits, the negligence of named defendants (Januvia (Sitagliptin) drugmakers) refers to their failure to properly warn the government, healthcare providers, and the public of the amount of NDMA in their drugs, violating U.S. consumer protection laws.

The types of Januvia (Sitagliptin) cancer lawsuits that have been filed include:

• Product liability (defective drug) lawsuits
• Personal injury lawsuits
• Wrongful death lawsuits

Several plaintiffs who have taken legal action against Januvia (Sitagliptin) drugmakers have not been diagnosed with cancer, but are nonetheless seeking compensation for the amount of money spent on Januvia (Sitagliptin) through their regular use of the drugs.

If you’ve been diagnosed with Leukemia after taking Januvia (Sitagliptin) and experienced significant financial or emotional distress, an attorney will likely recommend filing an individual lawsuit to seek fair compensation for your losses. You may be eligible to file a Januvia (Sitagliptin) lawsuit for Leukemia.

You can determine your eligibility for filing an individual lawsuit by speaking to an experienced dangerous drug attorney.

Liver Cancer

Overview Of Liver Cancer

Liver cancer is cancer that begins in the cells of your liver. Your liver is a football-sized organ that sits in the upper right portion of your abdomen, beneath your diaphragm and above your stomach.

Several types of cancer can form in the liver. The most common type of liver cancer is hepatocellular carcinoma, which begins in the main type of liver cell (hepatocyte). Other types of liver cancer, such as intrahepatic cholangiocarcinoma and hepatoblastoma, are much less common.

Cancer that spreads to the liver is more common than cancer that begins in the liver cells. Cancer that begins in another area of the body — such as the colon, lung or breast — and then spreads to the liver is called metastatic cancer rather than liver cancer. This type of cancer is named after the organ in which it began — such as metastatic colon cancer to describe cancer that begins in the colon and spreads to the liver.

Symptoms Of Liver Cancer

Most people don't have signs and symptoms in the early stages of primary liver cancer. When signs and symptoms do appear, they may include:

• Losing weight without trying
• Loss of appetite
• Upper abdominal pain
• Nausea and vomiting
• General weakness and fatigue
• Abdominal swelling
• Yellow discoloration of your skin and the whites of your eyes (jaundice)
• White, chalky stools

Causes Of Liver Cancer

Bladder cancer develops when cells in the bladder begin to grow abnormally. Rather than grow and divide in an orderly way, these cells develop mutations that cause them to grow out of control and not die. These abnormal cells form a tumor.

Causes of bladder cancer include:

• Smoking and other tobacco use
• Exposure to chemicals, especially working in a job that requires exposure to chemicals
• Past radiation exposure
• Chronic irritation of the lining of the bladder
• Parasitic infections, especially in people who are from or have traveled to certain areas outside the United States

It's not always clear what causes bladder cancer, and some people with bladder cancer have no obvious risk factors. Investigations are currently being conducted regarding the link to Januvia (Sitagliptin) Bladder Cancer.

Liver Cancer And Januvia (Sitagliptin)

Brand-name Januvia (Sitagliptin) products are commonly used in the United States and worldwide to treat Diabetes.

One of the types of cancer linked to overexposure to NDMA is liver cancer.

Many people who have taken Januvia (Sitagliptin) regularly, or have lost a loved one to cancer after using Januvia (Sitagliptin) products, are now suing Januvia (Sitagliptin) drugmakers for failing to disclose the potential link between use of their products and various cancers.

How To Know If Januvia (Sitagliptin) Caused Your Liver Cancer

Januvia (Sitagliptin) is a brand name for the generic drug, Januvia (Sitagliptin). Not all Januvia (Sitagliptin) products are necessarily believed to be contaminated with dangerous amounts of NDMA, according to the U.S. Food and Drug Administration.

If you are concerned about your risk for developing liver cancer after taking Januvia (Sitagliptin), or wish to know if Januvia (Sitagliptin) caused your liver cancer, your best course of action is to talk to your doctor or cancer treatment team. Your doctor can evaluate your risk, or probable causes of your liver cancer through careful consideration of your medical history and Januvia (Sitagliptin) use.

At this time, the FDA does not know how many people are likely to have been affected by the toxic amounts of NDMA in Januvia (Sitagliptin) and Januvia (Sitagliptin) products. An investigation into the scope of the issue and the likelihood of developing cancer after taking Januvia (Sitagliptin) is currently ongoing.

Multiple Myelomar

Overview Of Multiple Myeloma

Multiple myeloma is a cancer that forms in a type of white blood cell called a plasma cell. Plasma cells help you fight infections by making antibodies that recognize and attack germs.

Multiple myeloma causes cancer cells to accumulate in the bone marrow, where they crowd out healthy blood cells. Rather than produce helpful antibodies, the cancer cells produce abnormal proteins that can cause complications.

Treatment for multiple myeloma isn't always necessary for people who aren't experiencing any signs or symptoms. For people with multiple myeloma who require treatment, a number of treatments are available to help control the disease.

Symptoms Of Multiple Myeloma

Signs and symptoms of multiple myeloma can vary and, early in the disease, there may be none.

When signs and symptoms do occur, they can include:

• Bone pain, especially in your spine or chest
• Nausea
• Constipation
• Loss of appetite
• Mental fogginess or confusion
• Fatigue
• Frequent infections
• Weight loss
• Weakness or numbness in your legs
• Excessive thirst

Causes Of Multiple Myeloma

It's not clear what causes myeloma.

Doctors know that myeloma begins with one abnormal plasma cell in your bone marrow — the soft, blood-producing tissue that fills in the center of most of your bones. The abnormal cell multiplies rapidly.

Because cancer cells don't mature and then die as normal cells do, they accumulate, eventually overwhelming the production of healthy cells. In the bone marrow, myeloma cells crowd out healthy white blood cells and red blood cells, leading to fatigue and an inability to fight infections.

The myeloma cells continue trying to produce antibodies, as healthy plasma cells do, but the myeloma cells produce abnormal antibodies that the body can't use. Instead, the abnormal antibodies (monoclonal proteins, or M proteins) build up in the body and cause problems such as damage to the kidneys. Cancer cells can also cause damage to the bones that increases the risk of broken bones.

Multiple Myeloma And Januvia (Sitagliptin)

Brand-name Januvia (Sitagliptin) products are commonly used in the United States and worldwide to treat Diabetes.

One of the types of cancer linked to overexposure to NDMA is multiple myeloma.

Many people who have taken Januvia (Sitagliptin) regularly, or have lost a loved one to cancer after using Januvia (Sitagliptin) products, are now suing Januvia (Sitagliptin) drugmakers for failing to disclose the potential link between use of their products and various cancers.

How To Know If Januvia (Sitagliptin) Caused Your Multiple Myeloma

Januvia (Sitagliptin) is a brand name for the generic drug, Januvia (Sitagliptin). Not all Januvia (Sitagliptin) products are necessarily believed to be contaminated with dangerous amounts of NDMA, according to the U.S. Food and Drug Administration.

If you are concerned about your risk for developing multiple myeloma after taking Januvia (Sitagliptin), or wish to know if Januvia (Sitagliptin) caused your multiple myeloma, your best course of action is to talk to your doctor or cancer treatment team. Your doctor can evaluate your risk, or probable causes of your multiple myeloma through careful consideration of your medical history and Januvia (Sitagliptin) use.

At this time, the FDA does not know how many people are likely to have been affected by the toxic amounts of NDMA in Januvia (Sitagliptin) and Januvia (Sitagliptin) products. An investigation into the scope of the issue and the likelihood of developing cancer after taking Januvia (Sitagliptin) is currently ongoing.

What To Do If You Think Januvia (Sitagliptin) Caused Your Multiple Myeloma

If you were diagnosed with multiple myeloma after taking Januvia (Sitagliptin) regularly for a health problem, you are not alone. Several class action and individual lawsuits have been filed across the U.S. by individuals and loved ones who received a cancer diagnosis after taking Januvia (Sitagliptin) or Januvia (Sitagliptin) products.

The basis for these lawsuits is generally one of negligence. Negligence is a legal theory in personal injury law that traces personal injury or wrongful death to the negligent behavior of an individual or entity—such as a business or pharmaceutical company.

In the context of recent Januvia (Sitagliptin) lawsuits, the negligence of named defendants (Januvia (Sitagliptin) drugmakers) refers to their failure to properly warn the government, healthcare providers, and the public of the amount of NDMA in their drugs, violating U.S. consumer protection laws.

The types of Januvia (Sitagliptin) cancer lawsuits that have been filed include:

• Product liability (defective drug) lawsuits
• Personal injury lawsuits
• Wrongful death lawsuits

Several plaintiffs who have taken legal action against Januvia (Sitagliptin) drugmakers have not been diagnosed with cancer, but are nonetheless seeking compensation for the amount of money spent on Januvia (Sitagliptin) through their regular use of the drugs.

If you’ve been diagnosed with multiple myeloma after taking Januvia (Sitagliptin) and experienced significant financial or emotional distress, an attorney will likely recommend filing an individual lawsuit to seek fair compensation for your losses. You may be eligible to file a Januvia (Sitagliptin) lawsuit for multiple myeloma.

You can determine your eligibility for filing an individual lawsuit by speaking to an experienced dangerous drug attorney.

Ovarian Cancer

Overview Of Ovarian Cancer

Ovarian cancer is a type of cancer that begins in the ovaries. The female reproductive system contains two ovaries, one on each side of the uterus. The ovaries — each about the size of an almond — produce eggs (ova) as well as the hormones estrogen and progesterone.

Ovarian cancer often goes undetected until it has spread within the pelvis and abdomen. At this late stage, ovarian cancer is more difficult to treat. Early-stage ovarian cancer, in which the disease is confined to the ovary, is more likely to be treated successfully.

Surgery and chemotherapy are generally used to treat ovarian cancer.

Symptoms Of Ovarian Cancer

Early-stage ovarian cancer rarely causes any symptoms. Advanced-stage ovarian cancer may cause few and nonspecific symptoms that are often mistaken for more common benign conditions.

Signs and symptoms of ovarian cancer may include:

• Abdominal bloating or swelling
• Quickly feeling full when eating
• Weight loss
• Discomfort in the pelvis area
• Changes in bowel habits, such as constipation
• A frequent need to urinate

Causes Of Ovarian Cancer

It's not clear what causes ovarian cancer, though doctors have identified factors that can increase the risk of the disease.

In general, cancer begins when a cell develops errors (mutations) in its DNA. The mutations tell the cell to grow and multiply quickly, creating a mass (tumor) of abnormal cells. The abnormal cells continue living when healthy cells would die. They can invade nearby tissues and break off from an initial tumor to spread elsewhere in the body (metastasize).

Ovarian Cancer And Januvia (Sitagliptin)

Brand-name Januvia (Sitagliptin) products are commonly used in the United States and worldwide to treat Diabetes.

One of the types of cancer linked to overexposure to NDMA is Ovarian Cancer.

Many people who have taken Januvia (Sitagliptin) regularly, or have lost a loved one to cancer after using Januvia (Sitagliptin) products, are now suing Januvia (Sitagliptin) drugmakers for failing to disclose the potential link between use of their products and various cancers.

How To Know If Januvia (Sitagliptin) Caused Your Ovarian Cancer

Januvia (Sitagliptin) is a brand name for the generic drug, Januvia (Sitagliptin). Not all Januvia (Sitagliptin) products are necessarily believed to be contaminated with dangerous amounts of NDMA, according to the U.S. Food and Drug Administration.

If you are concerned about your risk for developing Ovarian Cancer after taking Januvia (Sitagliptin), or wish to know if Januvia (Sitagliptin) caused your Ovarian Cancer, your best course of action is to talk to your doctor or cancer treatment team. Your doctor can evaluate your risk, or probable causes of your Ovarian Cancer through careful consideration of your medical history and Januvia (Sitagliptin) use.

At this time, the FDA does not know how many people are likely to have been affected by the toxic amounts of NDMA in Januvia (Sitagliptin) and Januvia (Sitagliptin) products. An investigation into the scope of the issue and the likelihood of developing cancer after taking Januvia (Sitagliptin) is currently ongoing.

What To Do If You Think Januvia (Sitagliptin) Caused Your Ovarian Cancer

If you were diagnosed with Ovarian after taking Januvia (Sitagliptin) regularly for a health problem, you are not alone. Several class action and individual lawsuits have been filed across the U.S. by individuals and loved ones who received a cancer diagnosis after taking Januvia (Sitagliptin) or Januvia (Sitagliptin) products.

The basis for these lawsuits is generally one of negligence. Negligence is a legal theory in personal injury law that traces personal injury or wrongful death to the negligent behavior of an individual or entity—such as a business or pharmaceutical company.

In the context of recent Januvia (Sitagliptin) lawsuits, the negligence of named defendants (Januvia (Sitagliptin) drugmakers) refers to their failure to properly warn the government, healthcare providers, and the public of the amount of NDMA in their drugs, violating U.S. consumer protection laws.

The types of Januvia (Sitagliptin) cancer lawsuits that have been filed include:

• Product liability (defective drug) lawsuits
• Personal injury lawsuits
• Wrongful death lawsuits

Several plaintiffs who have taken legal action against Januvia (Sitagliptin) drugmakers have not been diagnosed with cancer, but are nonetheless seeking compensation for the amount of money spent on Januvia (Sitagliptin) through their regular use of the drugs.

If you’ve been diagnosed with Ovarian Cancer after taking Januvia (Sitagliptin) and experienced significant financial or emotional distress, an attorney will likely recommend filing an individual lawsuit to seek fair compensation for your losses. You may be eligible to file a Januvia (Sitagliptin) lawsuit for Ovarian Cancer.

You can determine your eligibility for filing an individual lawsuit by speaking to an experienced dangerous drug attorney.

Pancreatic Cancer

Overview Of Pancreatic Cancer

Pancreatic cancer begins in the tissues of your pancreas — an organ in your abdomen that lies behind the lower part of your stomach. Your pancreas releases enzymes that aid digestion and produces hormones that help manage your blood sugar.

Several types of growths can occur in the pancreas, including cancerous and noncancerous tumors. The most common type of cancer that forms in the pancreas begins in the cells that line the ducts that carry digestive enzymes out of the pancreas (pancreatic ductal adenocarcinoma).

Pancreatic cancer is seldom detected at its early stages when it's most curable. This is because it often doesn't cause symptoms until after it has spread to other organs.

Pancreatic cancer treatment options are chosen based on the extent of the cancer. Options may include surgery, chemotherapy, radiation therapy or a combination of these.

Symptoms Of Pancreatic Cancer

Signs and symptoms of pancreatic cancer often don't occur until the disease is advanced. They may include:

• Abdominal pain that radiates to your back
• Loss of appetite or unintended weight loss
• Yellowing of your skin and the whites of your eyes (jaundice)
• Light-colored stools
• Dark-colored urine
• Itchy skin
• New diagnosis of diabetes or existing diabetes that's becoming more difficult to control
• Blood clots
• Fatigue

Causes Of Pancreatic Cancer

It's not clear what causes pancreatic cancer. Doctors have identified some factors that may increase the risk of this type of cancer, including smoking and having certain inherited gene mutations.

Pancreatic Cancer And Januvia (Sitagliptin)

Brand-name Januvia (Sitagliptin) products are commonly used in the United States and worldwide to treat Diabetes.

One of the types of cancer linked to overexposure to NDMA is pancreatic cancer.

Many people who have taken Januvia (Sitagliptin) regularly, or have lost a loved one to cancer after using Januvia (Sitagliptin) products, are now suing Januvia (Sitagliptin) drugmakers for failing to disclose the potential link between use of their products and various cancers.

How To Know If Januvia (Sitagliptin) Caused Your Pancreatic Cancer

Januvia (Sitagliptin) is a brand name for the generic drug, Januvia (Sitagliptin). Not all Januvia (Sitagliptin) products are necessarily believed to be contaminated with dangerous amounts of NDMA, according to the U.S. Food and Drug Administration.

If you are concerned about your risk for developing pancreatic cancer after taking Januvia (Sitagliptin), or wish to know if Januvia (Sitagliptin) caused your pancreatic cancer, your best course of action is to talk to your doctor or cancer treatment team. Your doctor can evaluate your risk, or probable causes of your pancreatic cancer through careful consideration of your medical history and Januvia (Sitagliptin) use.

At this time, the FDA does not know how many people are likely to have been affected by the toxic amounts of NDMA in Januvia (Sitagliptin) and Januvia (Sitagliptin) products. An investigation into the scope of the issue and the likelihood of developing cancer after taking Januvia (Sitagliptin) is currently ongoing.

What To Do If You Think Januvia (Sitagliptin) Caused Your Pancreatic Cancer

If you were diagnosed with pancreatic cancer after taking Januvia (Sitagliptin) regularly for a health problem, you are not alone. Several class action and individual lawsuits have been filed across the U.S. by individuals and loved ones who received a cancer diagnosis after taking Januvia (Sitagliptin) or Januvia (Sitagliptin) products.

The basis for these lawsuits is generally one of negligence. Negligence is a legal theory in personal injury law that traces personal injury or wrongful death to the negligent behavior of an individual or entity—such as a business or pharmaceutical company.

In the context of recent Januvia (Sitagliptin) lawsuits, the negligence of named defendants (Januvia (Sitagliptin) drugmakers) refers to their failure to properly warn the government, healthcare providers, and the public of the amount of NDMA in their drugs, violating U.S. consumer protection laws.

The types of Januvia (Sitagliptin) cancer lawsuits that have been filed include:

• Product liability (defective drug) lawsuits
• Personal injury lawsuits
• Wrongful death lawsuits

Several plaintiffs who have taken legal action against Januvia (Sitagliptin) drugmakers have not been diagnosed with cancer, but are nonetheless seeking compensation for the amount of money spent on Januvia (Sitagliptin) through their regular use of the drugs.

If you’ve been diagnosed with pancreatic cancer after taking Januvia (Sitagliptin) and experienced significant financial or emotional distress, an attorney will likely recommend filing an individual lawsuit to seek fair compensation for your losses. You may be eligible to file a Januvia (Sitagliptin) lawsuit for pancreatic cancer.

You can determine your eligibility for filing an individual lawsuit by speaking to an experienced dangerous drug attorney.

Prostate Cancer

Overview Of Prostate Cancer

Prostate cancer is cancer that occurs in the prostate — a small walnut-shaped gland in men that produces the seminal fluid that nourishes and transports sperm.

Prostate cancer is one of the most common types of cancer in men. Usually prostate cancer grows slowly and is initially confined to the prostate gland, where it may not cause serious harm. However, while some types of prostate cancer grow slowly and may need minimal or even no treatment, other types are aggressive and can spread quickly.

Prostate cancer that's detected early — when it's still confined to the prostate gland — has a better chance of successful treatment.

Symptoms Of Prostate Cancer

Prostate cancer may cause no signs or symptoms in its early stages.

Prostate cancer that's more advanced may cause signs and symptoms such as:

• Trouble urinating
• Decreased force in the stream of urine
• Blood in semen
• Discomfort in the pelvic area
• Bone pain
• Erectile dysfunction

Causes Of Prostate Cancer

It's not clear what causes prostate cancer.

Doctors know that prostate cancer begins when some cells in your prostate become abnormal. Mutations in the abnormal cells' DNA cause the cells to grow and divide more rapidly than normal cells do. The abnormal cells continue living, when other cells would die. The accumulating abnormal cells form a tumor that can grow to invade nearby tissue. Some abnormal cells can also break off and spread (metastasize) to other parts of the body.

Investigations are under way regarding the link between prostate cancer and Januvia (Sitagliptin).

Prostate Cancer And Januvia (Sitagliptin)

Brand-name Januvia (Sitagliptin) products are commonly used in the United States and worldwide to treat Diabetes.

One of the types of cancer linked to overexposure to NDMA is prostate cancer.

Many people who have taken Januvia (Sitagliptin) regularly, or have lost a loved one to cancer after using Januvia (Sitagliptin) products, are now suing Januvia (Sitagliptin) drugmakers for failing to disclose the potential link between use of their products and various cancers.

How To Know If Januvia (Sitagliptin) Caused Your Prostate Cancer

Januvia (Sitagliptin) is a brand name for the generic drug, Januvia (Sitagliptin). Not all Januvia (Sitagliptin) products are necessarily believed to be contaminated with dangerous amounts of NDMA, according to the U.S. Food and Drug Administration.

If you are concerned about your risk for developing prostate cancer after taking Januvia (Sitagliptin), or wish to know if Januvia (Sitagliptin) caused your prostate cancer, your best course of action is to talk to your doctor or cancer treatment team. Your doctor can evaluate your risk, or probable causes of your prostate cancer through careful consideration of your medical history and Januvia (Sitagliptin) use.

At this time, the FDA does not know how many people are likely to have been affected by the toxic amounts of NDMA in Januvia (Sitagliptin) and Januvia (Sitagliptin) products. An investigation into the scope of the issue and the likelihood of developing cancer after taking Januvia (Sitagliptin) is currently ongoing.

What To Do If You Think Januvia (Sitagliptin) Caused Your Prostate Cancer

If you were diagnosed with prostate cancer after taking Januvia (Sitagliptin) regularly for a health problem, you are not alone. Several class action and individual lawsuits have been filed across the U.S. by individuals and loved ones who received a cancer diagnosis after taking Januvia (Sitagliptin) or Januvia (Sitagliptin) products.

The basis for these lawsuits is generally one of negligence. Negligence is a legal theory in personal injury law that traces personal injury or wrongful death to the negligent behavior of an individual or entity—such as a business or pharmaceutical company.

In the context of recent Januvia (Sitagliptin) lawsuits, the negligence of named defendants (Januvia (Sitagliptin) drugmakers) refers to their failure to properly warn the government, healthcare providers, and the public of the amount of NDMA in their drugs, violating U.S. consumer protection laws.

The types of Januvia (Sitagliptin) cancer lawsuits that have been filed include:

• Product liability (defective drug) lawsuits
• Personal injury lawsuits
• Wrongful death lawsuits

Several plaintiffs who have taken legal action against Januvia (Sitagliptin) drugmakers have not been diagnosed with cancer, but are nonetheless seeking compensation for the amount of money spent on Januvia (Sitagliptin) through their regular use of the drugs.

If you’ve been diagnosed with prostate cancer after taking Januvia (Sitagliptin) and experienced significant financial or emotional distress, an attorney will likely recommend filing an individual lawsuit to seek fair compensation for your losses. You may be eligible to file a Januvia (Sitagliptin) lawsuit for prostate cancer.

You can determine your eligibility for filing an individual lawsuit by speaking to an experienced dangerous drug attorney.

Stomach Cancer

Overview

Stomach cancer usually begins in the mucus-producing cells that line the stomach. This type of cancer is called adenocarcinoma.

For the past several decades, rates of cancer in the main part of the stomach (stomach body) have been falling worldwide. During the same period, cancer in the area where the top part of the stomach (cardia) meets the lower end of the swallowing tube (esophagus) has become much more common. This area of the stomach is called the gastroesophageal junction.

Symptoms

Signs and symptoms of gastroesophageal junction cancer and stomach cancer may include:

• Fatigue
• Feeling bloated after eating
• Feeling full after eating small amounts of food
• Severe, persistent heartburn
• Severe indigestion that is always present
• Unexplained, persistent nausea
• Stomach pain
• Persistent vomiting
• Unintentional weight loss

Causes

In general, cancer begins when an error (mutation) occurs in a cell's DNA. The mutation causes the cell to grow and divide at a rapid rate and to continue living when a normal cell would die. The accumulating cancerous cells form a tumor that can invade nearby structures. And cancer cells can break off from the tumor to spread throughout the body.

Gastroesophageal junction cancer is associated with having gastrointestinal reflux disease (GERD) and, less strongly, with obesity and smoking. GERD is a condition caused by frequent backflow of stomach acid into the esophagus.

There is a strong correlation between a diet high in smoked and salted foods and stomach cancer located in the main part of the stomach. As the use of refrigeration for preserving foods has increased around the world, the rates of stomach cancer have declined.

Stomach Cancer & Januvia (Sitagliptin)

Brand-name Januvia (Sitagliptin) products are commonly used in the United States and worldwide to treat Diabetes.

One of the types of cancer linked to overexposure to NDMA is stomach (gastric) cancer. Stomach cancer is diagnosed in an estimated 27,600 people in the U.S. each year, mostly in adults aged 65 and older.

Many people who have taken Januvia (Sitagliptin) regularly, or have lost a loved one to cancer after using Januvia (Sitagliptin) products, are now suing Januvia (Sitagliptin) drugmakers for failing to disclose the potential link between use of their products and various cancers.

How To Know If Januvia (Sitagliptin) Caused Your Stomach Cancer

Januvia (Sitagliptin) is a brand name for the generic drug, Januvia (Sitagliptin). Not all Januvia (Sitagliptin) products are necessarily believed to be contaminated with dangerous amounts of NDMA, according to the U.S. Food and Drug Administration.

If you are concerned about your risk for developing stomach cancer after taking Januvia (Sitagliptin), or wish to know if Januvia (Sitagliptin) caused your stomach cancer, your best course of action is to talk to your doctor or cancer treatment team. Your doctor can evaluate your risk, or probable causes of your stomach cancer through careful consideration of your medical history and Januvia (Sitagliptin) use.

At this time, the FDA does not know how many people are likely to have been affected by the toxic amounts of NDMA in Januvia (Sitagliptin) and Januvia (Sitagliptin) products. An investigation into the scope of the issue and the likelihood of developing cancer after taking Januvia (Sitagliptin) is currently ongoing.

What To Do If You Think Januvia (Sitagliptin) Caused Your Stomach Cancer

If you were diagnosed with cancer after taking Januvia (Sitagliptin) regularly for a health problem, you are not alone. Several class action and individual lawsuits have been filed across the U.S. by individuals and loved ones who received a cancer diagnosis after taking Januvia (Sitagliptin) or Januvia (Sitagliptin) products.

The basis for these lawsuits is generally one of negligence. Negligence is a legal theory in personal injury law that traces personal injury or wrongful death to the negligent behavior of an individual or entity—such as a business or pharmaceutical company.

In the context of recent Januvia (Sitagliptin) lawsuits, the negligence of named defendants (Januvia (Sitagliptin) drugmakers) refers to their failure to properly warn the government, healthcare providers, and the public of the amount of NDMA in their drugs, violating U.S. consumer protection laws.

The types of Januvia (Sitagliptin) cancer lawsuits that have been filed include:

• Product liability (defective drug) lawsuits
• Personal injury lawsuits
• Wrongful death lawsuits

Several plaintiffs who have taken legal action against Januvia (Sitagliptin) drugmakers have not been diagnosed with cancer, but are nonetheless seeking compensation for the amount of money spent on Januvia (Sitagliptin) through their regular use of the drugs.

If you’ve been diagnosed with stomach cancer after taking Januvia (Sitagliptin) and experienced significant financial or emotional distress, an attorney will likely recommend filing an individual lawsuit to seek fair compensation for your losses.

You can determine your eligibility for filing an individual lawsuit by speaking to an experienced dangerous drug attorney.